Tag: Kiran Mazumdar Shaw
BioVoice eMag February 2017 Issue-9 Volume-1
BioVoice eMag February 2017 Issue-9 Volume-1:
This edition of BioVoice in its detailed cover story highlights the gains and pains of the budget 2017. The...
Biocon wins INR 460 crore contract for Insulin from Malaysian govt
The company will supply rh-Insulin manufactured at its new facility in Malaysia to public sector hospitals and clinics through CCM Pharmaceuticals....
India’s prominent experts deliberate over its bio-economy power
Having embarked on a mission to achieve target of $100 billion strong bioscience industry by 2025, the stalwarts and stakeholders gathered at Delhi....
Delhi set to host ABLE’s BioEconomy Conclave 2016
The Association of Biotechnology Led Enterprises (ABLE) is organizing the BioEconomy India Conclave 2016 on November 29-30 at India Habitat Centre, Delhi....
Biocon’s net profit jumps to Rs 146.7 cr in 2nd quarter...
With consolidated net profit of Rs 146.7 crore, the biotechnology giant, Biocon has shown good performance for the second quarter of financial year 2016-17....
India gets new set of biosimilars guidelines, Industry welcomes move
While India has so far approved the manufacturing of 48 biosimilar products in the country, the biotechnology ...
Govt ignores Monsanto’s threats, slashes Bt Cotton subsidy by 70%
Despite statements from the global seeds giant that it will re-evaluate its India business if such a move is taken, the union government...
European Union opens doors to Biocon’s first generic formulation for the...
India's top biotech company, Biocon has announced that it has received European approvals for its Rosuvastatin Calcium 5 mg, 10 mg, 20 mg and...
Bioscience sector must get its due in this budget says Biocon...
The global economy is expected to slow down further in 2016 pulled down by weakness in major emerging economies like China, Brazil and Russia....